June 2020
Volume 61, Issue 7
ARVO Annual Meeting Abstract  |   June 2020
The effect of XFS-related factors on secreted extracellular vesicles from lung fibroblasts
Author Affiliations & Notes
  • Jingwen Cai
    Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, United States
  • Yan Yu
    Henan Institute of Science and Technology, Xinxiang, Henan, China
  • Yutao Liu
    Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, United States
  • Footnotes
    Commercial Relationships   Jingwen Cai, None; Yan Yu, None; Yutao Liu, None
  • Footnotes
    Support  NH Grant EY023242, EY028671, The Glaucoma Foundation, The Brightfocus Foundation, The Glaucoma Research Foundation
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 5017. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jingwen Cai, Yan Yu, Yutao Liu; The effect of XFS-related factors on secreted extracellular vesicles from lung fibroblasts. Invest. Ophthalmol. Vis. Sci. 2020;61(7):5017.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Exfoliation syndrome (XFS) is characterized with exfoliation material deposition in the eye and other organs, including lung. We aimed to determine the impact of XFS-related factors (TGFβ1, IL6, & glucose oxidase) on extracellular vesicles (EVs) derived from lung fibroblasts.

Methods : The lung fibroblast IMR90 cells were treated with TGFβ1 (10ng/ml), IL6 (50ng/ml), or glucose oxidase (GO) (8mU/ml) in FBS-free media for up to 48 hours. EVs were isolated using differential ultracentrifugation of 110,000g X 70 minutes twice. The resuspended EVs were analyzed with ZetaView and transmission electron microscopy (TEM) for particle size, concentration and morphology. The EVs from 48-hour treatment were used for mass spectrometry-based proteomic analysis (n=6) to identify differentially expressed (DE) proteins. Cellular lysates in 48-hour treated groups were also subjected to proteomics analysis (n=3) to identify DE cellular proteins under each treatment. The statistical analyses were performed using student t-test.

Results : EVs in all groups showed similar size range (100-150nm) and round, cup-shaped morphology under TEM. After 48-hour, all treated groups produced significantly more EVs than control groups. Proteomic analysis detected >30 exosome markers in each sample including CD63, CD81 and HSPA8. With TGFβ1 treatment, 45 EV DE proteins were enriched in focal adhesion, response to stress, and ECM. With IL6 treatment, 29 EV DE proteins were enriched in vesicle-mediated transport, lipid binding, and cytoskeleton regulation. With GO treatment, 13 DE proteins were enriched in response to wounding, collagen fibril organization, and cellular adhesion. The IPA identified TGFβ1, IL6R, and IGF2BP1 as upstream regulators of DE proteins in TGFβ1, IL6, and GO groups, respectively, further validating the relationship between treatment and EV DE proteins. Moreover, the DE proteins identified from cell lysates were enriched in similar classifications of EV DE proteins, such as focal adhesion and ECM-receptor interaction with TGFβ1 treatment, cytoskeletal protein binding with IL6 treatment, and extracellular organization with GO treatment, indicating the response of EVs to cellular changes.

Conclusions : XFS-related factors promoted EV release from lung fibroblasts with specific enriched proteins. These EVs may contribute to the ECM remodeling and serve as biomarkers for XFS.

This is a 2020 ARVO Annual Meeting abstract.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.